Skip to main content
. 2022 Aug 10;10:937595. doi: 10.3389/fbioe.2022.937595

FIGURE 4.

FIGURE 4

Immunohistochemistry analysis of mpHLOs. (A) Immunofluorescence staining of hiPSCs and FSCs for pluripotency markers NANOG and OCT4, posterior foregut marker CDX2, epithelial marker EpCAM. Immunofluorescence staining of mpHLOs for (B) hepatic maker HNF4α and mesenchymal marker VIM, (C) hepatic marker ALB, (D) epithelial marker EpCAM and hepatoblasts marker AFP, and (E) cholangiocyte marker CK19. (F–K) Semi-quantification analysis of immunofluorescence staining. Data are presented as the mean ± SD (n = 3) and analyzed by One-way analysis of variance, *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.